MOTTOLA FRANK (Sr VP, Quality, GMP Oper. & IT) received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2026ACC: 0001804567-26-000006
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
-977.00
Net shares
Net seller
$49.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.88K acquired · 2.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.88K
Price / share
—
Trade value
—
% of position
10.9%
2/25/2026
17.21K→19.08K
Common Stock
Direct
Shares
−977.00
Price / share
$50.69
Trade value
$49.52K
% of position
5.1%
2/25/2026
19.08K→18.11K
Total
Net shares
+898.00
Net value
-$49.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | A · Award | +1.88K | — | — | 10.9% | 17.21K | 19.08K |
| Common Stock Direct | 2/25/2026 | F · Tax Withholding | −977.00 | $50.69 | $49.52K | 5.1% | 19.08K | 18.11K |
| Total | +898.00 | -$49.52K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
1.88K shares
Shares
−1.88K
Strike price
Held after
1.88K
Exercisable
—
2/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock1.88K shares | 2/25/2026 | D · Disposition | −1.88K | — | 1.88K |